Advice Capital Robusto A/S: Financial statements 2019
CVR: 38264486
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Advice Capital Robusto A/S (CVR 38264486) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 4,507,219 compared with DKK -2,813,754 the year before. Equity in the 2019 report amounted to DKK 38,342,749. The solvency ratio was 96.8%.
- Profit/Loss
- DKK 4,507,219
- Equity
- DKK 38,342,749
- Total Assets
- DKK 39,601,482
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | 4.5M | 38.3M | - |
| 2018 | - | - | -2.8M | 19.9M | - |
| 2017 | - | - | -454K | 18.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Advice Capital Robusto A/S has published its annual report for 2018. The net result was DKK -2,813,754.
As of May 23, 2019, Peter Steen Hildebrandt has joined the board of directors of Advice Capital Robusto A/S.
As of May 23, 2019, Lars Einar Hansen has left the board of directors of Advice Capital Robusto A/S.
On May 23, 2019, the company changed its name from Advice Capital Long/Short Fund A/S to Advice Capital Breakthrough Biotech Fund A/S.
About Advice Capital Robusto A/S
Advice Capital Robusto A/S was a Danish company of the type Aktieselskab based in København K, founded in 2016. The company has been dissolved on 10 June 2024. The company was registered under the industry Investeringsselskaber. The company was previously named Advice Capital Breakthrough Biotech Fund A/S and Advice Capital Long/Short Fund A/S. The company has 1 employee (2021). In 2022, the company reported a net result of DKK -457,575 compared with DKK -16,694,589 the year before. Equity in the 2022 report amounted to DKK 327,813.